title: Response of conventional chondrosarcoma to gemcitabine alone: a case report.
abstract: Conventional skeletal chondrosarcoma is a bone neoplasm, which is poorly sensitive to anthracyclines-based chemotherapy. We report on an 18-month-long tumour response to gemcitabine as single agent in a young patient with an advanced secondary peripheral conventional chondrosarcoma, previously treated unsuccessfully with anthracyclines, ifosfamide, platinum, etoposide.
authors: Adult mesenchymal tumour & Rare cancer Medical Oncology Unit, Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, via G. Venezian, 1 I-20133 Milan, Italy.
authors: Salvatore
authors: S
authors: Provenzano
authors: Adult mesenchymal tumour & Rare cancer Medical Oncology Unit, Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, via G. Venezian, 1 I-20133 Milan, Italy.
authors: Nadia
authors: N
authors: Hindi
authors: Department of Radiology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
authors: Carlo
authors: C
authors: Morosi
authors: Medical Oncology Unit, Ospedale di Treviglio, Azienda Ospedaliera Treviglio, Treviglio, (BG) Italy.
authors: Mara
authors: M
authors: Ghilardi
authors: Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
authors: Paola
authors: P
authors: Collini
authors: Adult mesenchymal tumour & Rare cancer Medical Oncology Unit, Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, via G. Venezian, 1 I-20133 Milan, Italy.
authors: Paolo G
authors: PG
authors: Casali
authors: Adult mesenchymal tumour & Rare cancer Medical Oncology Unit, Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, via G. Venezian, 1 I-20133 Milan, Italy.
authors: Silvia
authors: S
authors: Stacchiotti
keywords: Bone sarcoma; Chemotherapy; Chondrosarcoma; Gemcitabine; Sarcoma